On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week in a positive fashion. The benchmark index rose 0.6% to 9,092.3 points.

Will the market be able to build on this on Monday? Here are five things to watch:

ASX 200 expected to fall

The Australian share market looks set for a poor start to the week following a subdued session on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 37 points or 0.4% lower. In the United States, the Dow Jones edged slightly lower, the S&P 500 fell 0.25%, and the Nasdaq dropped 0.5%.

Oil prices ease

It could be a subdued start to the week for ASX 200 energy shares Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) after oil prices eased on Friday night. According to Bloomberg, the WTI crude oil price was down 0.15% to US$83.40 a barrel and the Brent crude oil price was down 0.45% to US$88.10 a barrel. This was driven by news of some crude flows ​through the Strait of Hormuz.

Buy 4DMedical shares

4DMedical Ltd (ASX: 4DX) shares could be in the buy zone according to Bell Potter. This morning, in response to the healthcare technology company’s results, the broker has retained its speculative buy rating and $6.00 price target. It said: “4DX enters FY27 with good momentum at large hospital groups in the US. We expect on going revenue traction throughout the course of the year. Maintain Buy (Speculative) rating.”

Gold price sinks

It looks likely to be a poor start to the week for ASX 200 gold shares Capricorn Metals Ltd (ASX: CMM) and Northern Star Resources Ltd (ASX: NST) after the gold price sank on Friday night. According to CNBC, the gold futures price was down 2.9% to US$4,529.9 an ounce. Traders were selling gold in response to increasing US rate hike bets.

ASX 200 shares going ex-dividend

A number of ASX 200 shares are going ex-dividend this morning and could trade lower. Among them are health and safety products company Ansell Ltd (ASX: ANN), mineral sands company Iluka Resources Ltd (ASX: ILU), investment management company Pinnacle Investment Management Group Ltd (ASX: PNI), and rail freight company Aurizon Holdings Ltd (ASX: AZJ). The latter will be paying a 10.5 cents per share dividend to shareholders next month on 23 September.

The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.

More reading

• 5 superannuation mistakes that could shrink your nest egg
• Are ASX bank shares a buy in September?
• ASX 200 mining shares outperform in final week of earnings season
• Why gold stocks have regained their shine: Expert
• Could ASX shares crash? 5 questions every investor should ask now

Motley Fool contributor James Mickleboro has positions in Woodside Energy Group Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has recommended Ansell. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Pro Medicus Ltd (ASX: PME) share price has been one of the stronger performers over the last six months, rising by 44%. It’s a valid question to ask whether Pro Medicus can rise much further.

Pro Medicus describes itself as a leading healthcare informatics company. It provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide.

It offers a leading suite of radiology information systems (RIS), picture archiving and communication system (PACS), artificial intelligence and e-health solutions.

Strong recovery

Pro Medicus suffered a huge decline last year and early this year as the market worried about what AI could mean for the company’s future. However, the market seems to be a bit more positive about the situation.

It helps that the business continues to report an impressive set of numbers with its financials.

In the FY26 result, revenue grew 22.9% to $261.7 million, underlying operating profit (EBIT) grew 24.4% to $196.1 million and underlying net profit after tax (NPAT) rose 24.1% to $144.7 million.

The company has a significant presence in the US, so changes in foreign exchange rates can impact what it reports in Australian dollars. FY26 changes in currency hurt the financials.

If currency rates hadn’t changed, revenue would have increased 28.4% to $273.5 million, underlying EBIT would have gone up 30.6% to $206 million and underlying NPAT would have risen 32.5% to $154.5 million.

The impressive profit growth allowed the company to hike its payout by 25.5% to 37 cents per Pro Medicus share.

The future looks promising considering the underlying EBIT margin rose again to 74.9% in FY26, up from 74% in FY25. It continues to win sizeable contracts at an impressive pace, which is helping drive revenue.

Its latest contract win was a seven-year A$25 million contract with Valley Health, which includes the relatively new cardiology imaging offering. In that announcement, Pro Medicus said its pipeline is strong and spans all market segments.

How much could the Pro Medicus share price rise in the next year?

According to CMC Invest, there have been 10 analyst ratings on the business within the last three months.

A price target tells us where an analyst thinks a share price could go in the next 12 months. The average price target of those 10 ratings is $220.14, according to CMC Invest, suggesting a possible rise of 21% over the next year.

The most optimistic price target is $240, suggesting a possible rise of 32%.

So, analysts are excited about the future of the business and it could still be one to watch.

The post How much could the Pro Medicus share price rise in the next year? appeared first on The Motley Fool Australia.

More reading

• Warren Buffett’s playbook: 3 cheap ASX shares that could soar up to 60%
• 3 ASX shares I’d buy for the next 15 years
• Buy, hold, sell: Pro Medicus, Fortescue, CBA shares
• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus
• Why Guzman Y Gomez, Pro Medicus and James Hardie shares are turning heads on Friday

Motley Fool contributor Tristan Harrison has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There are not many ASX dividend stocks that I’d prefer to own rather than receive the cash flow of the Age Pension. WCM Quality Global Growth Fund (ASX: WCMQ) is one of the passive income choices I’d pick.

The exchange-traded fund (ETF) may not be as famous as names like Commonwealth Bank of Australia (ASX: CBA), BHP Group Ltd (ASX: BHP) or Rio Tinto Ltd (ASX: RIO). But, for various reasons, I think the WCMQ ETF offers investors more positives and potentially stronger long-term returns.

For me, there are three reasons to like the investment so much.

Excellent and diversified portfolio

WCM is a fund manager that’s based in Laguna Beach, California. That’s deliberately a long way from the culture of Wall Street in New York.

The investment strategy of the fund is to invest in a portfolio of high-quality shares from across the world.

There are two main factors that go into deciding whether the business is high-quality for this ASX dividend stock’s portfolio.

First, WCM wants to see that the business has an expanding economic moat (improving competitive advantages). For WCM, the direction of the moat is more important than the actual size of the moat.

One of the main ways that WCM judges whether a business is seeing a strengthening economic moat is with a rising return on invested capital (ROIC). This shows that the company’s economics are getting stronger.

Second, WCM analyses whether the business has a corporate culture that supports improvement of the economic moat.

The portfolio is truly global – it’s not massively focused on the US share market. Its portfolio is invested across the Americas, Europe, Asia Pacific and elsewhere.

Its holdings regularly change, but its sector exposure typically focuses on IT, industrials and healthcare names. It also has positions in financials, consumer discretionary and others.

Great passive income

The WCMQ ETF offers investors a solid distribution yield, which is based on its net asset value (NAV).

The fund targets a distribution yield of 5%, which I’d say is a solid starting yield and I think the payments will rise over time thanks to WCMQ ETF’s pleasing investment track record.

A rising NAV over time should lead to growing payouts for investors.

Capital growth

In its July 2026 update, the ASX dividend stock revealed that its portfolio had returned an average of 15.2% per year since the ETF’s inception in August 2018.

With that level of return, the fund has been able to deliver both its pleasing dividend yield and the retained returns have helped grow the WCMQ ETF unit price over the long-term – it has approximately doubled in the last eight years.

Past performance is not a guarantee of future performance, of course, but I’m optimistic the fund can deliver pleasing returns, including capital growth. That’s why I think the ASX dividend stock is so appealing.

How to match the Age Pension with the ASX dividend stock

Currently the Age Pension is paying a maximum of approximately $1,200 per fortnight, though this will increase in the coming weeks. That translates into annualised income of $31,200.

The ETF expects to pay an annual distribution of 53.6 cents per security in FY27. That translates into needing 58,209 WCMQ ETF units to unlock the same level of cash payment. I’m also optimistic the ETF’s payout can grow at a faster pace than the Age Pension in the coming years. However, I’d also want to diversify my portfolio, rather than relying on one idea.

The post 58,209 shares of this high-yield ASX dividend stock pays an income equal to the Age Pension appeared first on The Motley Fool Australia.

More reading

• 2 ASX passive income ideas I’d use to generate $300 a month in 2027
• How much do I need to retire on $120,000 a year at 55?
• How much is needed in superannuation to target a $5,500 monthly passive income?
• How much is needed in superannuation to target a $40,000 annual passive income?

Motley Fool contributor Tristan Harrison has positions in Wcm Quality Global Growth Fund. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.